GENE ONLINE|News &
Opinion
Blog

PD-1
The Next Decade in Cancer Therapeutics: How Immunotherapy is Evolving from Efficacy to Precision
2026-05-05
Lepu, HanX Scores China Approval For PD-1 Inhibitor
2022-07-27
Zhiyi Biotech Finishes Series B Funding With $45 Million For Live Biotherapeutics
2022-07-11
BioNTech and Regeneron Expands Cancer Vaccine Collab, Adds Lung Cancer Indication
2022-03-10
Another Homegrown Anti-PD-1 Antibody Scores Regulatory Win in China
2021-08-31
Genentech Seeks FDA’s Blessings after Adjuvant Tecentriq Shows Promising Result in Lung Cancer Patients
2021-03-23
FDA Approves Treatment for Aggressive Form of Mesothelioma After Sixteen Long Years
2020-10-04
A New Imaging Tool Predicts Response of Cancer Patients to Immune Checkpoint Inhibition Therapy
2020-08-30
Roche’s Tecentriq Bags Landmark FDA Approval as First-Line Monotherapy for Metastatic NSCLC
2020-05-20
CRISPR-Edited T cells Evaluated in Combating Lung Cancer
2020-05-10
AACR 2020 – Changing the Immunotherapy Paradigm
2020-05-08
Gut Bacteria and Cancer: From Cancer Development to Precision Medicine
2020-03-29
Roche Identifies Biomarker that Determines Patient Response to Immunotherapy
2020-03-15
Top 5 News from the World of CRISPR Gene Editing
2019-04-26
Erdafitinib Approval,a Bright Spot Amid the Troughs in Bladder Cancer Trials
2019-04-23
1 2
LATEST
EirGenix Leverages Dual Engines of CDMO and Biosimilars to Capitalize on Global Biopharma Supply Chain Realignment
2026-06-11
nVent Electric Appoints New Chief Strategy and Revenue Officers
2026-06-10
Snail Games Announces Bellwright Console Launch and New ARK Content at IGN Live 2026
2026-06-10
BJJLink Launches AI-Powered Platform for Martial Arts Gym Member Acquisition
2026-06-10
Trump Media and TAE Technologies Provide Merger Status Update on June 10, 2026
2026-06-10
OZOP Energy Solutions Partners with Tenace Consulting for Southern California Distribution
2026-06-10
Agassi Sports Entertainment Signs Darren Cahill to Lead Global Coaching and Technology Initiatives
2026-06-10
Scroll to Top